These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 9066679

  • 41. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
    Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gonçalves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF.
    Front Biosci (Landmark Ed); 2022 Aug 16; 27(8):245. PubMed ID: 36042160
    [Abstract] [Full Text] [Related]

  • 42. [Comparative Proteomic Analysis of Human Lung Adenocarcinoma Cisplatin-resistant Cell Strain A549/CDDP.].
    Shi S, Wang J, Zhai W, Gao G, Tang J, Fan K, Tang Z, Wei L.
    Zhongguo Fei Ai Za Zhi; 2009 Nov 20; 12(11):1155-8. PubMed ID: 20723362
    [Abstract] [Full Text] [Related]

  • 43. Proteomic profiling of cisplatin-resistant and cisplatin-sensitive germ cell tumour cell lines using quantitative mass spectrometry.
    Fichtner A, Bohnenberger H, Elakad O, Richter A, Lenz C, Oing C, Ströbel P, Kueffer S, Nettersheim D, Bremmer F.
    World J Urol; 2022 Feb 20; 40(2):373-383. PubMed ID: 35084545
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Binding activities of cis-platin-damage-recognition proteins in human tumour cell lines.
    McLaughlin K, Coren G, Masters J, Brown R.
    Int J Cancer; 1993 Feb 20; 53(4):662-6. PubMed ID: 8436440
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Complementation analysis of testis tumor cells.
    Wang X, Hafezparast M, Masters JR.
    Cancer Genet Cytogenet; 1997 Oct 01; 98(1):56-62. PubMed ID: 9309119
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors.
    Bakardjieva-Mihaylova V, Skvarova Kramarzova K, Slamova M, Svaton M, Rejlova K, Zaliova M, Dobiasova A, Fiser K, Stuchly J, Grega M, Rosova B, Zachoval R, Klezl P, Eis V, Kindlova E, Buchler T, Trka J, Boublikova L.
    Cancers (Basel); 2019 Sep 06; 11(9):. PubMed ID: 31500094
    [Abstract] [Full Text] [Related]

  • 52. [Effects of CDDP on the serum LDH isozymes in rabbits and patients with gallbladder cancer in urinary organs].
    Yamaoka K, Yamada K, Toyoshima A, Yasuda K, Ikeda R, Okinaga M, Nakagawa S, Okinaga T.
    Gan To Kagaku Ryoho; 1986 Dec 06; 13(12):3546-8. PubMed ID: 3789764
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Biochemical parameters in the diagnosis and monitoring of neurotoxicity of antitumor cytostatics.
    Lyubimova NV, Toms MG, Shakirova IN, Gurina OI, Kushlinskii NE.
    Bull Exp Biol Med; 2001 Nov 06; 132(5):1093-5. PubMed ID: 11865330
    [Abstract] [Full Text] [Related]

  • 55. Testicular cancer: Genetic determinants of cisplatin resistance.
    Thoma C.
    Nat Rev Urol; 2016 Nov 06; 13(11):629. PubMed ID: 27698397
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
    de Graaf TW, de Jong S, de Vries EG, Mulder NH.
    Anticancer Res; 1997 Nov 06; 17(1A):369-75. PubMed ID: 9066679
    [Abstract] [Full Text] [Related]

  • 58. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T.
    Clin Cancer Res; 1996 Feb 06; 2(2):427-32. PubMed ID: 9816187
    [Abstract] [Full Text] [Related]

  • 59. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.